China ‘outpacing the US’ in biotech race to find cure for Parkinson’s disease
Chinese researchers, specifically Nuwacell Biotechnologies, claim to be leading the global race for a Parkinson's disease cure using stem cell therapies. The company's chief scientist, Yu Junying, stated their therapy converts into dopaminergic neurons at an 80-90% efficiency rate, significantly higher than the reported sub-25% efficiency of international competitors. This advancement is attributed to faster clinical trial timelines and higher overall efficiency in their approach. AI
IMPACT Potential breakthrough in Parkinson's treatment could significantly impact patient care and the broader biotech industry.